ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ZTEK Zentek Ltd

1.035
0.0151 (1.48%)
Last Updated: 15:37:39
Delayed by 15 minutes

Period:

Draw Mode:

Volume 15,524
Bid Price 1.03
Ask Price 1.04
News -
Day High 1.048

Low
0.974999

52 Week Range

High
1.7494

Day Low 1.0165
Company Name Stock Ticker Symbol Market Type
Zentek Ltd ZTEK NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0151 1.48% 1.035 15:37:39
Open Price Low Price High Price Close Price Prev Close
1.02 1.0165 1.048 1.0199
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
103 15,524 $ 1.03 $ 16,033 - 0.974999 - 1.7494
Last Trade Time Type Quantity Stock Price Currency
15:49:49 5 $ 1.035 USD

Zentek Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
140.14M 100.82M - 73k -14.41M -0.14 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Zentek News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ZTEK Message Board. Create One! See More Posts on ZTEK Message Board See More Message Board Posts

Historical ZTEK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.091.161.001.0422,087-0.055-5.05%
1 Month1.251.251.001.1018,263-0.215-17.20%
3 Months1.431.45911.001.2119,798-0.395-27.62%
6 Months1.281.590.9749991.2122,461-0.245-19.14%
1 Year1.491.74940.9749991.3221,328-0.455-30.54%
3 Years3.003.780.9749992.5455,357-1.97-65.50%
5 Years3.003.780.9749992.5455,357-1.97-65.50%

Zentek Description

Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection and treatment.?It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19,?and the potential to use?similar?compounds?as pharmaceutical products?against infectious diseases. The company also has an exclusive agreement to be the global commercializing partner for a newly developed, highly scalable, aptamer-based rapid pathogen detection technology.

Your Recent History

Delayed Upgrade Clock